InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.00%
)
US TECH 100
19,187.20
(
-0.46%
)
Dow Jones
39,169.52
(
0.00%
)
Brent Oil
87.19
(
0.76%
)
Bitcoin
62,719.66
(
-0.21%
)
Post# of 19455
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

No1Uknow

Send PM Follow Ignore
Followers 33
Posts 1496
Boards Moderated 0
Alias Born 12/06/2016

No1Uknow

Re: None

Thursday, 03/18/2021 10:32:58 AM

Thursday, March 18, 2021 10:32:58 AM

Post# of 19455
Float 10,190,900...COVID 19 breakthrough...OTC PINK: (QNTA), announced today positive results in a safety and toxicity study conducted on its polarized drug candidate derived from a small molecular peptide found in scorpions, designed to treat patients with the SARS-CoV-2 virus, also known as COVID-19. The results showed no signs of toxicity in any of the patients involved in the study who were given the drug Escozine®, which is a polarized solution of the Rhopalurus princeps scorpion peptide owned by Medolife.

Do your research, take your position, turn off the noise.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up